Bleeding risk as one of major hurdles in stroke prevention therapy prescription.
Event:
ESC Congress 2018
Congress Presentation
About the speaker
Professor Christopher B Granger
Duke University Medical Center, Durham (United States of America)
15
presentations
1
follower
2 more presentations in this session
Novel biomarker-based risk scores for better stratification of stroke and major bleeding risk in AF patients and OAC therapy optimization.
Speaker: Associate Professor Z. Hijazi (Uppsala, SE)
How do we assess anticoagulant activity in emergency situations in NOAC treated AF patients?
Speaker: Professor P. Kamphuisen (Hilversum, NL)
Access the full session
Biomarker-based approaches for improved atrial fibrillation management
Speakers:
Professor C. Granger, Associate Professor Z. Hijazi, Professor P. Kamphuisen
About the event
ESC 365 is supported by
